Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    -5.00 (-2.20%)
Bid:
222.00
Ask:
232.00
Spread: 10.00 (4.505%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Microgen Aptitude Modules Launch

15 Sep 2010 07:00

RNS Number : 6850S
Microgen PLC
15 September 2010
 



microgen

www.microgen.com

 

15 September 2010

 

 

 

MICROGEN LAUNCHES THREE NEW MICROGEN APTITUDE SOFTWARE MODULES

 

Microgen plc (Microgen' or 'the Group') today launches three new modules for its flagship Business Process Platform, Microgen Aptitude. The new modules provide substantial performance improvements on the already market-leading capability of Microgen Aptitude and maintain Microgen's position as the technology leader in this category. The modules build on the performance and functionality of Microgen Aptitude Version 3.0, introduced in June 2010.

 

The new Microgen Aptitude Version 3.0 Modules are:

 

Microgen Aptitude DBClarity - This new capability within Microgen Aptitude functionality positions Microgen at the forefront of the emerging technology of in-database analytics, providing substantial performance improvements to database-intensive applications. Through its graphical interface, Microgen Aptitude DBClarity addresses one of the major functional weaknesses of current in-database analytics which are written in the database language resulting in a lack of transparency and auditability for non-programmers. For the first time, a business will be able to address this weakness and develop high performance in-database analytical applications via a graphical interface thereby reducing operational risk, speeding up the analysis process and improving collaboration between the business and IT.

 

Microgen Aptitude PerformancePLUS - Building on the market leading performance of Microgen Aptitude Version 3.0, the Microgen Aptitude PerformancePLUS module delivers transaction processing speeds that are up to a further 30 per cent faster. Such speeds are critical in high-volume and complex transaction environments such as digital media and retail banking. This performance improvement is achieved by, amongst other leading edge developments, the adoption of Microgen's innovative fast enrichment process, for which a patent has been filed making a total of 12 patents now filed associated with the Microgen Aptitude technology.

 

Microgen Aptitude BPD & SOA Orchestration - This module enables SOA orchestration from entities within the Business Process Diagram (BPD) providing the ability to merge new and old technologies, such as the integration of cloud services with legacy systems to create an agile environment that can respond rapidly to the speed of business change. With Microgen Aptitude BPD & SOA Orchestration, both IT and business users can now build and deploy flexible applications quickly within a Service Orientated Architecture (SOA) environment.

 

These new modules for Microgen Aptitude maintain Microgen's technology leadership position at the forefront of high volume processing in complex transaction environments. Microgen's market-leading capability has been further extended in terms of both performance and functionality. Furthermore, in-database analytics are increasingly being adopted as a necessary development to increase performance of database-intensive applications and Microgen has addressed one of the major limitations of current market solutions.

 

Contacts

Martyn Ratcliffe, Chairman 01252-772300

David Sherriff, Chief Operating Officer

Philip Wood, Group Finance Director

 

James Melville-Ross, Financial Dynamics 020-7831-3113

Haya Herbert-Burns, Financial Dynamics

 

Copyright © 2010 Microgen plc All Rights Reserved Microgen ® Microgen plc Microgen Aptitude ® Microgen Aptitude Limited Microgen Aptitude - Patent Pending (Serial No: 1686466) & U.S. Patents Pending

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLLLFLRALISLII
Date   Source Headline
4th May 20218:55 amRNSTotal Voting Rights
29th Apr 20217:00 amRNSAppointment of Joint Broker
27th Apr 202111:28 amRNSResult of AGM
27th Apr 20217:00 amRNSAGM Statement
9th Apr 202111:14 amRNSHolding(s) in Company
29th Mar 20212:06 pmRNSBlock listing Interim Review
23rd Mar 202111:13 amRNSDirector/PDMR Shareholding
11th Mar 20214:44 pmRNSBlock Listing Application
2nd Mar 20217:00 amRNSNotice of Results
1st Mar 202112:36 pmRNSTotal Voting Rights
19th Jan 20217:00 amRNSTrading Update
6th Jan 20214:23 pmRNSHolding(s) in Company
4th Jan 20217:00 amRNSTotal Voting Rights
18th Dec 20209:13 amRNSHolding(s) in Company
1st Dec 202010:09 amRNSTotal Voting Rights
23rd Nov 20205:37 pmRNSHolding(s) in Company
28th Oct 20201:58 pmRNSDirector/PDMR Shareholding
29th Sep 20204:41 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
28th Sep 202010:48 amRNSBlock listing Interim Review
9th Sep 20204:24 pmRNSGrant of awards under Performance Share Plan
2nd Sep 20201:38 pmRNSDirector Declaration
11th Aug 202012:19 pmRNSDirector/PDMR Shareholding
29th Jul 20207:00 amRNSInterim Results
6th Jul 20207:23 amRNSHolding(s) in Company
6th Jul 20207:21 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSTrading Update and Notice of Results
11th Jun 20204:41 pmRNSSecond Price Monitoring Extn
11th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20204:35 pmRNSPrice Monitoring Extension
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
1st May 20207:00 amRNSTotal Voting Rights
29th Apr 202012:16 pmRNSDisclosure of Rights attached to Ordinary Shares
28th Apr 202012:45 pmRNSResult of AGM
21st Apr 20207:00 amRNSCOVID-19 Update and AGM Arrangements
8th Apr 20205:02 pmRNSDirector/PDMR Shareholding
8th Apr 20204:59 pmRNSDirector/PDMR Shareholding
27th Mar 202012:38 pmRNSBlock listing Interim Review
18th Mar 20205:00 pmRNSAnnual Report and Notice of AGM
16th Mar 20201:52 pmRNSBlock Listing Application
13th Mar 20205:11 pmRNSDirector/PDMR Shareholding
11th Mar 20207:00 amRNSAudited Preliminary Results
13th Feb 20205:26 pmRNSHolding(s) in Company
3rd Feb 20201:54 pmRNSTotal Voting Rights
22nd Jan 20202:44 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSTrading Update, Board Changes & Notice of Results
15th Jan 202012:01 pmRNSHolding(s) in Company
3rd Jan 202012:07 pmRNSSecond Price Monitoring Extn
3rd Jan 202012:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.